Faculty, Staff and Student Publications
Publication Date
10-1-2023
Journal
Molecular Aspects of Medicine
DOI
10.1016/j.mam.2023.101204
PMID
37478804
PMCID
PMC10528439
PubMedCentral® Posted Date
10-1-2024
PubMedCentral® Full Text Version
Author MSS
Abstract
Lynch Syndrome (LS) is one of the most common hereditary cancer syndromes, and is caused by mutations in one of the four DNA mismatch repair (MMR) genes, namely MLH1, MSH2, MSH6 and PMS2. Tumors developed by LS carriers display high levels of microsatellite instability, which leads to the accumulation of large numbers of mutations, among which frameshift insertion/deletions (indels) within microsatellite (MS) loci are the most common. As a result, MMR-deficient (MMRd) cells generate increased rates of tumor-specific neoantigens (neoAgs) that can be recognized by the immune system to activate cancer cell killing. In this context, LS is an ideal disease to leverage immune-interception strategies. Therefore, the identification of these neoAgs is an ongoing effort for the development of LS cancer preventive vaccines. In this review, we summarize the computational methods used for in silico neoAg prediction, including their challenges, and the experimental techniques used for in vitro validation of their immunogenicity. In addition, we outline results from past and on-going vaccine clinical trials and highlight avenues for improvement and future directions.
Keywords
Humans, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA-Binding Proteins, MutL Protein Homolog 1, Mismatch Repair Endonuclease PMS2, Vaccine Development, Lynch Syndrome, Neoantigens, MMR deficiency, Colorectal cancer, Immune prevention, Cancer vaccines
Published Open-Access
yes
Recommended Citation
Bolivar, Ana M; Duzagac, Fahriye; Sinha, Krishna M; et al., "Advances in Vaccine Development for Cancer Prevention and Treatment in Lynch Syndrome" (2023). Faculty, Staff and Student Publications. 5073.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5073
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons